# Methotrexate Infusion and Intrasilicone Injection During Diabetic Vitrectomy

> **NCT06038968** · EARLY_PHASE1 · COMPLETED · sponsor: **Minia University** · enrollment: 60 (actual)

## Conditions studied

- Diabetic Retinopathy
- Vitreomacular Traction

## Interventions

- **DRUG:** Methotrexate 25 MG/ML
- **PROCEDURE:** parsplana vitrectomy

## Key facts

- **NCT ID:** NCT06038968
- **Lead sponsor:** Minia University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-01
- **Primary completion:** 2023-11-01
- **Final completion:** 2024-01-01
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2024-02-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06038968

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06038968, "Methotrexate Infusion and Intrasilicone Injection During Diabetic Vitrectomy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06038968. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*